Table 3.
Model Performance of the BCSC and BBD-BC Models
| BCSC | ||||||
|---|---|---|---|---|---|---|
| Endpoint | N | Concordance Invasive BC (%) | C-statistic (95% CI) | Observed Events | Calibration Predicted Events | Pred./Obs. (95% CI) |
| Screening Cohort* | ||||||
| 5 years | 1089 | 20 (1.8%) | 0.59 (0.46, 0.71) | 20 | 26.12 | 1.31 (0.94, 2.25) |
| 10 years | 1089 | 54 (5.0%) | 0.63 (0.56, 0.71) | 54 | 51.02 | 0.94 (0.85, 1.43) |
| BBD-BC | ||||||
| Endpoint | N | Concordance Invasive or DCIS BC (%) | C-statistic (95% CI) | Calibration Observed Events | Predicted Events | Pred./Obs. (95% CI) |
| Screening Cohort* | ||||||
| 5 years | 1089 | 27 (2.5%) | 0.69 (0.58, 0.80) | 27 | 29.93 | 1.11 (0.84, 1.77) |
| 10 years | 1089 | 69 (6.3%) | 0.66 (0.59, 0.73) | 69 | 57.54 | 0.83 (0.77, 1.20) |
| Full BBD Cohort** | ||||||
| 5 years | 2142 | 56 (2.6%) | 0.68 (0.60, 0.75) | 56 | 49.70 | 0.89 (0.71, 1.21) |
| 10 years | 2142 | 118 (5.5%) | 0.66 (0.60, 0.71) | 118 | 95.34 | 0.81 (0.70, 1.00) |
BCSC= Breast Cancer Surveillance Consortium; BBD-BD= Benign Breast Disease to Breast Cancer; DCIS=ductal carcinoma in situ; BC=Breast Cancer; Pred. = Predicted; Obs. = Observed;
Screening cohort, n=1089 ages 35–74 and with mammogram;
Full cohort, n=2142, ages 18 and up